# agilon health, inc. (AGL) Stock Analysis: Potential 58% Upside Amidst Revenue Growth

- Link: https://www.directorstalkinterviews.com/agilon-health-inc-agl-stock-analysis-potential-58-upside-amidst-revenue-growth/4121245087
- Published: 2026-03-17T11:25:01+00:00
- Author: Madison Wilson

For investors navigating the volatile waters of healthcare stocks, agilon health,
inc. (NYSE: AGL) presents a tantalizing opportunity. With a projected potential 
upside of 58.63%, this healthcare provider might pique the interest of those seeking
to capitalize on an evolving sector.

Operating within the medical care facilities industry, agilon health, inc. has carved
out a niche by offering healthcare services tailored for seniors through a network
of primary care physicians across the United States. The company’s innovative model
focuses on managing the comprehensive healthcare needs of its patients through a
subscription-like per-member per-month platform. Since its inception in 2016 and
subsequent rebranding in 2021, agilon health has been headquartered in Westerville,
Ohio.

The company’s current market cap stands at $246.93 million, with a stock price hovering
around 0.5952 USD. Despite a minimal price change of -0.01%, agilon health remains
in the sights of investors, partly due to its substantial 52-week range fluctuation
from 0.35 to 5.68 USD. These figures highlight both the volatility and potential
within this investment.

Valuation metrics paint a complex picture. The absence of a trailing P/E ratio and
a negative forward P/E of -3.34 suggest that profitability remains a challenge for
agilon health. This is further emphasized by a concerning EPS of -0.98 and a staggering
return on equity of -135.64%. The lack of dividend yield also signals that income-
focused investors may need to look elsewhere for immediate returns.

Despite these hurdles, agilon health has demonstrated a modest revenue growth of
3.10%, underscoring its capacity to expand within its niche. However, the significant
free cash flow deficit of -81,226,128.00 USD points to cash flow challenges that
the company needs to address to sustain and enhance its growth trajectory.

Analysts have expressed mixed sentiments, with 2 buy ratings, 13 hold ratings, and
2 sell ratings. The spectrum of target prices, ranging from 0.25 to 2.00 USD, results
in an average target of 0.94 USD, which supports the intriguing potential upside
of nearly 59%. Investors should approach with caution, balancing this potential 
against the inherent risks.

Technical indicators offer additional insights. The stock’s 50-day moving average
is 0.69 USD, while the 200-day moving average is higher at 1.14 USD, suggesting 
a bearish trend. An RSI of 48.66 reflects a relatively neutral position, neither
overbought nor oversold, while the MACD and signal line indicators suggest a stable,
albeit cautious, outlook.

As agilon health continues to navigate the challenges of its operating environment,
its unique business model and focus on senior healthcare provide a meaningful differentiation.
Investors interested in agilon health, inc. should consider both its growth potential
and financial [sustainability](https://www.directorstalkinterviews.com/sustainability-green-stocks-news),
weighing these against the broader healthcare market dynamics. With an eye on potential
upside, those willing to embrace the risks may find this stock an intriguing addition
to a diversified portfolio.

Share on: